Updated:
Update your bookmarks
This page now contains information that used to be on the COVID-19 Situational Awareness Dashboard.
A downloadable .csv data file is located at the bottom right of the map of Canada. Please update your bookmarks.
Summary of COVID-19 cases across Canada and over time. Contains detailed data about the spread of the virus over time and in different regions of the country. Includes breakdowns by age and sex or gender. Provides an overview of hospitalizations and deaths, testing, variants of concern and exposures.
Key updates as of
Daily epidemiology update: Text description
| Cases today | {Cases today} |
|---|---|
| Total cases | {Total cases} |
| Active | {Active} |
| Total resolved | {Total resolved} |
| Deaths today | {Deaths today} |
| Total deaths | {Total deaths} |
| Total tests performed | {Tests performed today} |
| Daily percent positive (last 7 days) | {Daily percent positive (last 7 days)}% |
| Daily tests per 100,000 population (last 7 days) | {Rate tests} |
Current situation
Figure 1a.
of
of COVID-19, by
as of
Hover over or tap provinces and territories to see total cases, active cases, resolved cases, tests performed or deaths in Canada over time. Click the play button to animate the map. Map data is available in .csv and .json formats and a data dictionary is available .csv format.
The count of total cases of COVID-19 in Canada was 1,471 as of .
No Trend Data Available
This information is based on data our provincial and territorial partners published on cases, deaths, and testing daily, and are current as of the day they are published. Today’s numbers are current as of . For the most up to date data for any province, territory or city, please visit their website. The number of cases or deaths reported on previous days may differ slightly from those on the provincial and territorial websites as these websites may update historic case and death counts as new information becomes available.
Figure 1a: Text description
| Location | Total cases | Cases last 7 days | Active cases | Resolved | Deaths | Deaths last 7 days | Total tests performed | Moving average tests performed last 7 days | Moving average positivity last 7 days | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Count | Rate* | Count | Rate* | Count | Rate* | Count | Count | Rate* | Count | Rate* | Count | Count | Rate* | Percent | |
* Rate per 100,000 population
| Province | Health Region | Total cases | Cases last 14 days | Deaths | Deaths last 14 days | ||||
|---|---|---|---|---|---|---|---|---|---|
| Count | Rate* | Count | Rate* | Count | Rate* | Count | Rate* | ||
‡ No data is available for this day, and so the most recently available data is displayed.
† Rate per 1,000,000 population
* Rate per 100,000 population
Figure 1b. of of COVID-19 in Canada as of
The figures below show cases over time. The range of dates (January 31st, 2020 – present date) is the same for each figure. This allows you to compare the provinces and territories on the same timescale.
Figure 1b: Text description
National overview
There have been over (Num tests} COVID-19 tests performed in Canada or {Rate tests} tests per 1 million people. For information about testing trends, please see the Detailed weekly epidemiological report (PDF).
| Location | New cases | New deaths | Tests performed |
|---|
* The new cases, deaths and tests reflect the difference between a province or territory’s current report and their last report. Some provinces and territories do not update daily.
N/A means that no daily update was provided by the province or territory.
COVID-19 variants in Canada
All viruses, including COVID-19, change over time. These changes are called mutations, and result in variants of the virus. Not all mutations are of concern. Most do not cause more severe illness. However, some mutations result in variants of concern or variants of interest.
A variant of concern has mutations that are significant to public health. Before a variant of interest is considered one of concern, scientists and public health professionals must determine if the mutations result in an actual change in the behaviour of the virus. For example, it might:
- spread more easily
- cause more severe illness
- require different treatments, or
- reduce vaccine effectiveness
There are several variants of interest that have mutations similar to variants of concern, but we don’t yet know if they pose a higher risk to public health.
The Public Health Agency of Canada (PHAC) works with provincial and territorial partners and the Canadian COVID-19 Genomics Network (CanCOGeN) to sequence a percentage of all positive COVID-19 test results. Sequencing reveals the genetic code of the virus, which tells us which variant is involved in a specific case of COVID-19. We report the proportion of COVID-19 variants in Canada every week.
We collect evidence to determine if new variants meet the definition for a variant of concern or a variant of interest. Many variants are being tracked across Canada and around the world. Variants of concern now represent a majority of COVID-19 cases in Canada.
Four VOCs have been detected in most provinces and territories:
- B.1.1.7 (Alpha)
- B.1.351 (Beta)
- P.1 (Gamma)
- B.1.617.2 (Delta)
New variants will continue to appear. We must remain vigilant and take all available measures to limit spread.
Figure 2. Weekly variant breakdown Updated: November 5, 2021, 4 pm EDT download weekly variant breakdown data in .csv format
The graphic shows the percentage mix of COVID-19 variants detected in Canada through whole genome sequencing, by week of sample collection. You can see the numbers for each date by hovering over, tabbing to, or long-pressing any of the bars. To see a specific variant or variant grouping, click or press return. Repeat to restore the complete graph.
This information is based on whole genome sequencing from surveillance testing in all provinces and territories. In addition to sequencing done by the National Microbiology Laboratory in Winnipeg, data is included from provincial and territorial laboratories.
Sequencing takes from 1 to 3 weeks to complete, so the proportions for recent weeks may change as more data are added. Surveillance in each province or territory is organized and prioritized according to local needs and may change from time to time. Because of differences in local sampling and reporting, the percentages illustrate trends rather than precise measurements.
Weekly variant breakdown
Percentage of COVID-19 cases identified through whole genome sequencing, presented by variant and by week of sample collection.
Figure 2: Text description
Contributing laboratories:
- National Microbiology Laboratory (NML) – supplemental sequencing for all provinces and territories
Detailed case information
The tables and figures below reflect detailed case information provided to the Public Health Agency of Canada (PHAC) by health authorities in the provinces and territories. This data is updated every week. It may change as we get more information about cases.
Updated: June 25, 2021, 9 am EDT
Epidemic curve
As of June 25, 2021, 9 am EDT, PHAC has received detailed case report data on cases. Both exposure and symptom onset date were available for (%) casesFootnote 1.
The shaded area on the far right of Figure 3 represents a period of accumulating data. This is the period of time (1 to 2 weeks) before the latest cases are reported to PHAC. This delay is a result of the time required to seek health care, get tested and receive results. It also takes time for public health authorities to gather information on cases. We update this information as it becomes available.
Figure 3. COVID-19 cases (n=Footnote 1) in Canada by dateFootnote 2 as of () Footnote 3
Figure 3. COVID-19 cases (n=Footnote 1) in Canada by dateFootnote 2 as of (total cases)
Figure 3. COVID-19 cases (n=Footnote 1) in Canada by dateFootnote 2 as of (by exposure)
Figure 3. COVID-19 cases (n=Footnote 1) in Canada by dateFootnote 2 as of (by age – 10 year groups)
Figure 3. COVID-19 cases (n=Footnote 1) in Canada by dateFootnote 2 as of (by age – 20 year groups)
This figure may underestimate the total number of cases among returning travelers. Exposure history is not available for all cases and jurisdictions have not all consistently reported exposure history to PHAC throughout the pandemic.
Figure 3: Text description
| DateFootnote 2 | Newly reported casesFootnote 1 | Domestic – Contact with a COVID case | Domestic – Contact with a traveller | Domestic – Unknown | Travelled outside of Canada | Information pending |
|---|
Demographics
We have detailed case report data from 99,853 cases. We know the age of patients in 99.78% of cases, and both age and gender in 99.98% of cases.
Of the cases reported in Canada so far, {Percent Gender} were {Gender} and {Percent of Over 60} were between 20 and 39 years old (Figure 4).
Figure 4.
Figure 4: Text description
| Age group (years) | Number of cases with case reports (percentage) | Number of male cases (percentage) | Number of female cases (percentage) | Number of other cases (percentage) |
|---|
How people were exposed Footnote 3
In , detailed case report data were provided for 877,276 cases. We have exposure history for 923,042 (89%) cases. The probable exposure setting of these casesFootnote 1 are:
- any exposure that occurred in Canada: {Spread} ({Percent spread}%), including
- from contact with a known COVID case: {Spread contact} ({Percent spread}%)
- from contact with a traveller: {Spread traveller} ({Percent spread}%)
- from an unknown source: {Spread unknown} ({Percent spread}%)
- currently unknown (information pending): {Unknown pending} ({Percent unknown pending}%)
- travelled outside of Canada: {Travelled} ({Percent travelled}%)
Cases following vaccination
Data extracted on for cases from December 14, 2020 up until July 10, 2021.
While the COVID-19 vaccines are effective, there is still a small percentage of the population who are vaccinated that will still be infected with COVID-19 if they are exposed to the virus that causes it. This means that even with high vaccine effectiveness, a small percentage of the population who are vaccinated against COVID-19 will still get sick and some may be hospitalized or even die as a result of their illness. It is also possible that a person could be infected just before or just after vaccination and still get sick. It typically takes about two weeks for the body to build protection after vaccination, so a person could get sick if the vaccine has not had enough time to provide protection.
Cases reported since the start of the vaccination campaign, as of July 03, 2021
Since the start of the vaccination campaign on December 14, 2020, PHAC received case-level vaccine history data for 75.5% (n=624,980) of COVID-19 cases aged 12 years or older.
Of these cases:
- () were unvaccinated at the time of their episode date
- () were not yet protected by the vaccine, as their episode date occurred less than 14 days after their first dose
- () were only partially vaccinated, as their episode date occurred either 14 days or more after their first dose or less than 14 days after their second dose
- () were fully vaccinated, as their episode date occurred 14 days or more after their second dose
Figure 5. of confirmed COVID-19 cases reported to PHAC by vaccination status as of July 10, 2021
Figure 5: Text description
| Status | Cases | Hospitalizations | Deaths |
|---|
July 10, 2021.
Of these people:
Based on detailed case information reported to PHAC from provinces and territories, cases following vaccination were reported more frequently among females and those aged 60 years and older (Table 2). This may be the result of higher vaccination coverage in Canada among females and those aged 60 years and older due to the prioritization of older age groups and healthcare workers as part of the vaccine rollout.
- Source: Detailed case information received by PHAC from provinces and territories, since December 14, 2020
- Note:
- There are currently twelve jurisdictions reporting case-level vaccine history data to PHAC as part of the national COVID-19 dataset. A data cut-off of July 10, 2021 was used to account for any reporting delays associated with vaccine history information.
- *Cases with missing gender were excluded. Where available, gender data was used; when gender data was unavailable, sex data was used. Reliable data on gender diverse respondents are unavailable due to small counts.
Fully vaccinated individuals diagnosed with COVID-19 were significantly protected from severe outcomes. Compared to unvaccinated cases, fully vaccinated cases were XX% less likely to be hospitalized and XX% less likely to die as a result of their illness (Table 3).
Table 3. Risk of severe outcomes among fully vaccinated cases compared to unvaccinated cases as of July 10, 2021
- *Adjusted for 10-year age groups and month of episode date
- Source: Detailed case information received by PHAC from provinces and territories
- Note: Due to the nature of the dataset (i.e. confirmed cases of COVID-19 in Canada), the odds of severe outcomes among cases following vaccination only considers vaccinated individuals that contracted COVID-19. It does not reflect the protection conferred by the vaccines to prevent COVID-19 infection.
Definitions
Data for this analysis is extracted from the COVID-19 national data set, which contains detailed case-level information received by PHAC from all provinces and territories. Note that a data cut-off of July 10, 2021 was used to account for any reporting delays associated with vaccine history information. There are currently twelve jurisdictions reporting case-level vaccine history data to PHAC as part of the national COVID-19 dataset.
PHAC monitors cases following vaccination using the following categories:
- Unvaccinated cases: include those who were unvaccinated at the time of their episode date.
- Cases not yet protected from vaccination include those whose episode date occurred less than 14 days after their first dose of the vaccine.
- Partially vaccinated cases include those whose episode date occurred 14 days or more after their first vaccine dose or less than 14 days after their second dose of the vaccine.
- Fully vaccinated cases include those whose episode date occurred 14 days or more after their second dose of a two dose vaccine series or those whose episode date occurred 14 days or more after one dose of a one-dose vaccine.
Note: When symptom onset date is unavailable or the case is asymptomatic, episode date uses the following dates as a proxy for classification: laboratory specimen collection date, or laboratory testing date.
For more information on cases following vaccination, please see the Weekly epidemiology report (PDF) available on the Government of Canada’s COVID-19 data trends page.
Severe illness and outcomes
Hospital use
Figure 6: Text description
| Date | Number of patients hospitalized | Number of patients in the ICU | Number of patients who were mechanically vented |
|---|
Between October 10 and Oct 17:
- the number of hospital beds occupied by COVID-19 patients increased from 785 to 934 beds.
- the number of ICU beds occupied by COVID-19 patients increased from 160 to 181 beds.
- the number of COVID-19 patients who were mechanically vented increased from 785 to 934.
Hospitalizations and deaths to date
We have detailed case report data on 99,853 cases, and hospitalization status for 65,597 (xx%) of them:
- {Num Hospitalized} cases ({Percent Hospitalized}%) were hospitalized, of whom:
- {Num Intensive Care} ({Percent Intensive Care}%) were admitted to the ICU
- {Num Mechanical Ventilation} ({Percent Mechanical Ventilation}%) needed mechanical ventilation
The provinces and territories provided detailed case report forms for {Num Deaths} deaths related to COVID-19.
Figure 7a. Age and genderFootnote 4 distribution of COVID-19 cases hospitalized in Canada as of (n=Footnote 1)
Figure 7b. Age and genderFootnote 4 distribution of COVID-19 cases admitted to ICU in Canada as of (n=Footnote 1)
Figure 7c. Age and genderFootnote 4 distribution of COVID-19 cases deceased in Canada as of (n=Footnote 1)
Data note: Figure 7 includes COVID-19 cases hospitalized, admitted to ICU, and deceased for which age and gender information were available. Therefore, some COVID-19 hospitalizations, ICU admissions, and deaths may not be included in Figure 7.
Figure 7: Text description
| Age group (years) | Number of cases with case reports (percentage) | Number of male cases (percentage) | Number of female cases (percentage) | Number of other cases (percentage) |
|---|
| Age group (years) | Number of cases with case reports (percentage) | Number of male cases (percentage) | Number of female cases (percentage) | Number of other cases (percentage) |
|---|
| Age group (years) | Number of cases with case reports (percentage) | Number of male cases (percentage) | Number of female cases (percentage) | Number of other cases (percentage) |
|---|
Provincial, territorial and international reporting
For more information, please refer to provincial or territorial COVID-19 webpages:
Additional COVID-19 data resources
- Date modified: